Printer Friendly

Switzerland : Lonza Pharma&Biotech Launches Ibex Solutions An Innovative New Concept in Biological Manufacturing and Development.

Lonzas commitment to constant innovation and adding value to its customers and partners is today demonstrated by the launch of Ibex Solutions a unique addition to its current offering.

Ibex Solutions is an innovative new biological development and manufacturing concept, coupling flexibility in facility-build-out with fully tailored business models and leveraging Lonza's expertise and service network in Visp (CH). Construction began in June with a formal groundbreaking ceremony expected in the second half of 2017. Several hundred new positions are expected to be created.

Ibex biomanufacturing comprises a modular, technology-independent development and manufacturing complex capable of supporting activities across multiple technologies mammalian, microbial, cellular or bio-conjugate and from late discovery to manufacture. This flexibility gives customers complete freedom in facility design and implementation, and the ability to respond rapidly as their needs evolve.

Responsiveness is further enhanced by the integration of the Ibex biomanufacturing complex into the Visp site with its experienced workforce and established service networks.

Ibex Solutions include highly flexible models to match and adapt to each customers expectations and forecasts. The availability of a modular complex means time-to-market can be reduced by 12 months or more. These advantages contribute to a significant de-risking of major strategic investment decisions.

Lonzas Pharma&Biotech COO, Marc Funk, commented: Lonza has been creating innovative manufacturing and production solutions for 120 years, and we are continuing to pioneer clinical and commercial manufacturing in multiple technologies all over the world. We have been working with our partners to understand what we can offer that will really change the game for them, and thats why we have created Ibex.

[c] 2017 Al Bawaba ( Provided by SyndiGate Media Inc. ( ).

COPYRIGHT 2017 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Mena Report
Date:Jul 27, 2017
Previous Article:Switzerland : Lonza Delivers Strong Performance in First Half 2017 and Sets a Strong Foundation for Continued Attractive Mid-Term Growth.
Next Article:Canada : Helping Black Youth Succeed Through Mentorship.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters